This form of heart failure is especially common among people with obesity and Type 2 diabetes
Patients who struggle with appetite control, cravings, and overeating are often good candidates for GLP-1, particularly if theyve already tried a traditional diet and exercise without success
This is where MeAgain's GLP-1 app fits in: it centralizes dose timelines, symptom and hydration logs, and lab entries, enabling clinicians to interpret test changes more quickly and precisely
adults are currently taking GLP-1 medications for weight loss, which is a huge jump from the 3% who said they were using the drugs in 2024
Are using tirzepatide and concerned about regulatory risk
Injection-Site Reactions Redness, tenderness, swelling, itching, or irritation may occur around a subcutaneous injection site